Yoga management of breast cancer-related lymphoedema: a randomised controlled pilot-trial.
Identifieur interne : 001461 ( PubMed/Corpus ); précédent : 001460; suivant : 001462Yoga management of breast cancer-related lymphoedema: a randomised controlled pilot-trial.
Auteurs : Annette Loudon ; Tony Barnett ; Neil Piller ; Maarten A. Immink ; Andrew D. WilliamsSource :
- BMC complementary and alternative medicine [ 1472-6882 ] ; 2014.
English descriptors
- KwdEn :
- MESH :
- pathology : Breast Neoplasms, Lymphedema.
- therapy : Breast Neoplasms, Lymphedema.
- Adult, Aged, Aged, 80 and over, Female, Humans, Middle Aged, Pain Measurement, Pilot Projects, Quality of Life, Self Care, Yoga.
Abstract
Secondary arm lymphoedema continues to affect at least 20% of women after treatment for breast cancer requiring lifelong professional treatment and self-management. The holistic practice of yoga may offer benefits as an adjunct self-management option. The aim of this small pilot trial was to gain preliminary data to determine the effect of yoga on women with stage one breast cancer-related lymphoedema (BCRL). This paper reports the results for the primary and secondary outcomes.
DOI: 10.1186/1472-6882-14-214
PubMed: 24980836
Links to Exploration step
pubmed:24980836Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Yoga management of breast cancer-related lymphoedema: a randomised controlled pilot-trial.</title>
<author><name sortKey="Loudon, Annette" sort="Loudon, Annette" uniqKey="Loudon A" first="Annette" last="Loudon">Annette Loudon</name>
</author>
<author><name sortKey="Barnett, Tony" sort="Barnett, Tony" uniqKey="Barnett T" first="Tony" last="Barnett">Tony Barnett</name>
</author>
<author><name sortKey="Piller, Neil" sort="Piller, Neil" uniqKey="Piller N" first="Neil" last="Piller">Neil Piller</name>
</author>
<author><name sortKey="Immink, Maarten A" sort="Immink, Maarten A" uniqKey="Immink M" first="Maarten A" last="Immink">Maarten A. Immink</name>
</author>
<author><name sortKey="Williams, Andrew D" sort="Williams, Andrew D" uniqKey="Williams A" first="Andrew D" last="Williams">Andrew D. Williams</name>
<affiliation><nlm:affiliation>School of Health Sciences, University of Tasmania, Launceston, Australia. Andrew.Williams@utas.edu.au.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24980836</idno>
<idno type="pmid">24980836</idno>
<idno type="doi">10.1186/1472-6882-14-214</idno>
<idno type="wicri:Area/PubMed/Corpus">001461</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001461</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Yoga management of breast cancer-related lymphoedema: a randomised controlled pilot-trial.</title>
<author><name sortKey="Loudon, Annette" sort="Loudon, Annette" uniqKey="Loudon A" first="Annette" last="Loudon">Annette Loudon</name>
</author>
<author><name sortKey="Barnett, Tony" sort="Barnett, Tony" uniqKey="Barnett T" first="Tony" last="Barnett">Tony Barnett</name>
</author>
<author><name sortKey="Piller, Neil" sort="Piller, Neil" uniqKey="Piller N" first="Neil" last="Piller">Neil Piller</name>
</author>
<author><name sortKey="Immink, Maarten A" sort="Immink, Maarten A" uniqKey="Immink M" first="Maarten A" last="Immink">Maarten A. Immink</name>
</author>
<author><name sortKey="Williams, Andrew D" sort="Williams, Andrew D" uniqKey="Williams A" first="Andrew D" last="Williams">Andrew D. Williams</name>
<affiliation><nlm:affiliation>School of Health Sciences, University of Tasmania, Launceston, Australia. Andrew.Williams@utas.edu.au.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">BMC complementary and alternative medicine</title>
<idno type="eISSN">1472-6882</idno>
<imprint><date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Breast Neoplasms (pathology)</term>
<term>Breast Neoplasms (therapy)</term>
<term>Female</term>
<term>Humans</term>
<term>Lymphedema (pathology)</term>
<term>Lymphedema (therapy)</term>
<term>Middle Aged</term>
<term>Pain Measurement</term>
<term>Pilot Projects</term>
<term>Quality of Life</term>
<term>Self Care</term>
<term>Yoga</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Breast Neoplasms</term>
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Female</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Pain Measurement</term>
<term>Pilot Projects</term>
<term>Quality of Life</term>
<term>Self Care</term>
<term>Yoga</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Secondary arm lymphoedema continues to affect at least 20% of women after treatment for breast cancer requiring lifelong professional treatment and self-management. The holistic practice of yoga may offer benefits as an adjunct self-management option. The aim of this small pilot trial was to gain preliminary data to determine the effect of yoga on women with stage one breast cancer-related lymphoedema (BCRL). This paper reports the results for the primary and secondary outcomes.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24980836</PMID>
<DateCreated><Year>2014</Year>
<Month>07</Month>
<Day>07</Day>
</DateCreated>
<DateCompleted><Year>2014</Year>
<Month>10</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>08</Month>
<Day>05</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1472-6882</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>14</Volume>
<PubDate><Year>2014</Year>
<Month>Jul</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>BMC complementary and alternative medicine</Title>
<ISOAbbreviation>BMC Complement Altern Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Yoga management of breast cancer-related lymphoedema: a randomised controlled pilot-trial.</ArticleTitle>
<Pagination><MedlinePgn>214</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/1472-6882-14-214</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Secondary arm lymphoedema continues to affect at least 20% of women after treatment for breast cancer requiring lifelong professional treatment and self-management. The holistic practice of yoga may offer benefits as an adjunct self-management option. The aim of this small pilot trial was to gain preliminary data to determine the effect of yoga on women with stage one breast cancer-related lymphoedema (BCRL). This paper reports the results for the primary and secondary outcomes.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Participants were randomised, after baseline testing, to receive either an 8-week yoga intervention (n = 15), consisting of a weekly 90-minute teacher-led class and a 40-minute daily session delivered by DVD, or to a usual care wait-listed control group (n = 13). Primary outcome measures were: arm volume of lymphoedema measured by circumference and extra-cellular fluid measured by bioimpedance spectroscopy. Secondary outcome measures were: tissue induration measured by tonometry; levels of sensations, pain, fatigue, and their limiting effects all measured by a visual analogue scale (VAS) and quality of life based on the Lymphoedema Quality of Life Tool (LYMQOL). Measurements were conducted at baseline, week 8 (post-intervention) and week 12 (four weeks after cessation of the intervention).</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">At week 8, the intervention group had a greater decrease in tissue induration of the affected upper arm compared to the control group (p = 0.050), as well as a greater reduction in the symptom sub-scale for QOL (p = 0.038). There was no difference in arm volume of lymphoedema or extra-cellular fluid between groups at week 8; however, at week 12, arm volume increased more for the intervention group than the control group (p = 0.032).</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">An 8-week yoga intervention reduced tissue induration of the affected upper arm and decreased the QOL sub-scale of symptoms. Arm volume of lymphoedema and extra-cellular fluid did not increase. These benefits did not last on cessation of the intervention when arm volume of lymphoedema increased. Further research trials with a longer duration, higher levels of lymphoedema and larger numbers are warranted before definitive conclusions can be made.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Loudon</LastName>
<ForeName>Annette</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Barnett</LastName>
<ForeName>Tony</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Piller</LastName>
<ForeName>Neil</ForeName>
<Initials>N</Initials>
</Author>
<Author ValidYN="Y"><LastName>Immink</LastName>
<ForeName>Maarten A</ForeName>
<Initials>MA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Williams</LastName>
<ForeName>Andrew D</ForeName>
<Initials>AD</Initials>
<AffiliationInfo><Affiliation>School of Health Sciences, University of Tasmania, Launceston, Australia. Andrew.Williams@utas.edu.au.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y"><DataBank><DataBankName>ANZCTR</DataBankName>
<AccessionNumberList><AccessionNumber>ACTRN12611000202965</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016448">Multicenter Study</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2014</Year>
<Month>07</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>BMC Complement Altern Med</MedlineTA>
<NlmUniqueID>101088661</NlmUniqueID>
<ISSNLinking>1472-6882</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2000 Sep;33(3):122-35</RefSource>
<PMID Version="1">11019400</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Support Care Cancer. 2013 Aug;21(8):2207-15</RefSource>
<PMID Version="1">23494582</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphology. 1976 Mar;9(1):1-5</RefSource>
<PMID Version="1">1263567</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Pain. 1986 Dec;27(3):401-11</RefSource>
<PMID Version="1">3808744</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Pain Symptom Manage. 1992 Feb;7(2):110-6</RefSource>
<PMID Version="1">1573284</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Support Care Cancer. 2005 Nov;13(11):904-11</RefSource>
<PMID Version="1">15812652</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2005 Sep;38(3):136-45</RefSource>
<PMID Version="1">16353491</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphology. 2005 Dec;38(4):167-80</RefSource>
<PMID Version="1">16515225</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2007 Oct 1;25(28):4387-95</RefSource>
<PMID Version="1">17785709</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2008 Jul 20;26(21):3536-42</RefSource>
<PMID Version="1">18640935</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Rehabil Med. 2008 Aug;40(8):651-8</RefSource>
<PMID Version="1">19020699</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Med Sci Sports Exerc. 2009 Mar;41(3):483-9</RefSource>
<PMID Version="1">19204604</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lymphat Res Biol. 2009;7(2):109-12</RefSource>
<PMID Version="1">19534633</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncol Nurs Forum. 2009 Jul;36(4):454-62</RefSource>
<PMID Version="1">19581236</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2009 Aug 13;361(7):664-73</RefSource>
<PMID Version="1">19675330</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer Invest. 2010 Jan;28(1):54-62</RefSource>
<PMID Version="1">19916749</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Pain Symptom Manage. 2009 Dec;38(6):849-59</RefSource>
<PMID Version="1">19819668</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Exerc Sport Sci Rev. 2010 Jan;38(1):17-24</RefSource>
<PMID Version="1">20016295</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Support Care Cancer. 2010 Mar;18(3):383-92</RefSource>
<PMID Version="1">19495810</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Occup Ther. 2010 Jan-Feb;64(1):59-72</RefSource>
<PMID Version="1">20131565</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Psychooncology. 2010 Mar;19(3):299-305</RefSource>
<PMID Version="1">19399782</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Soc Integr Oncol. 2010 Spring;8(2):43-55</RefSource>
<PMID Version="1">20388445</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Dermatol. 2011 Mar;50(3):310-34</RefSource>
<PMID Version="1">21342165</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Altern Complement Med. 2011 Sep;17(9):867-9</RefSource>
<PMID Version="1">21875352</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cancer. 2012 Apr 15;118(8 Suppl):2237-49</RefSource>
<PMID Version="1">22488698</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Complement Altern Med. 2012;12:66</RefSource>
<PMID Version="1">22639944</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Oncologist. 2012;17(8):1120-8</RefSource>
<PMID Version="1">22752068</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Cancer. 2012;12:412</RefSource>
<PMID Version="1">22988934</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Oncol. 2003 Feb 1;21(3):463-6</RefSource>
<PMID Version="1">12560436</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010147" MajorTopicYN="N">Pain Measurement</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012648" MajorTopicYN="N">Self Care</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015013" MajorTopicYN="Y">Yoga</DescriptorName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4083036</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2013</Year>
<Month>07</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2014</Year>
<Month>06</Month>
<Day>23</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2014</Year>
<Month>7</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2014</Year>
<Month>7</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2014</Year>
<Month>10</Month>
<Day>21</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">24980836</ArticleId>
<ArticleId IdType="pii">1472-6882-14-214</ArticleId>
<ArticleId IdType="doi">10.1186/1472-6882-14-214</ArticleId>
<ArticleId IdType="pmc">PMC4083036</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001461 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001461 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:24980836 |texte= Yoga management of breast cancer-related lymphoedema: a randomised controlled pilot-trial. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:24980836" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |